336 related articles for article (PubMed ID: 29410442)
1. Ischemia augments alloimmune injury through IL-6-driven CD4
Uehara M; Solhjou Z; Banouni N; Kasinath V; Xiaqun Y; Dai L; Yilmam O; Yilmaz M; Ichimura T; Fiorina P; Martins PN; Ohori S; Guleria I; Maarouf OH; Tullius SG; McGrath MM; Abdi R
Sci Rep; 2018 Feb; 8(1):2461. PubMed ID: 29410442
[TBL] [Abstract][Full Text] [Related]
2. Transient blockade of delta-like Notch ligands prevents allograft rejection mediated by cellular and humoral mechanisms in a mouse model of heart transplantation.
Wood S; Feng J; Chung J; Radojcic V; Sandy-Sloat AR; Friedman A; Shelton A; Yan M; Siebel CW; Bishop DK; Maillard I
J Immunol; 2015 Mar; 194(6):2899-908. PubMed ID: 25687759
[TBL] [Abstract][Full Text] [Related]
3. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
4. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
5. Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells.
Tsuda H; Su CA; Tanaka T; Ayasoufi K; Min B; Valujskikh A; Fairchild RL
JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467328
[TBL] [Abstract][Full Text] [Related]
6. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response.
Duan L; Wang CY; Chen J; Gong Q; Zhu P; Zheng F; Tan Z; Gong F; Fang M
Lab Invest; 2011 Jan; 91(1):43-53. PubMed ID: 20714327
[TBL] [Abstract][Full Text] [Related]
8. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection.
Ferrari-Lacraz S; Zheng XX; Kim YS; Li Y; Maslinski W; Li XC; Strom TB
J Immunol; 2001 Sep; 167(6):3478-85. PubMed ID: 11544341
[TBL] [Abstract][Full Text] [Related]
9. Novel Application of Localized Nanodelivery of Anti-Interleukin-6 Protects Organ Transplant From Ischemia-Reperfusion Injuries.
Solhjou Z; Uehara M; Bahmani B; Maarouf OH; Ichimura T; Brooks CR; Xu W; Yilmaz M; Elkhal A; Tullius SG; Guleria I; McGrath MM; Abdi R
Am J Transplant; 2017 Sep; 17(9):2326-2337. PubMed ID: 28296000
[TBL] [Abstract][Full Text] [Related]
10. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
11. IL-17A Is Critical for CD8+ T Effector Response in Airway Epithelial Injury After Transplantation.
Zhang R; Fang H; Chen R; Ochando JC; Ding Y; Xu J
Transplantation; 2018 Dec; 102(12):e483-e493. PubMed ID: 30211827
[TBL] [Abstract][Full Text] [Related]
12. Defective CD8 Signaling Pathways Delay Rejection in Older Recipients.
Bedi DS; Krenzien F; Quante M; Uehara H; Edtinger K; Liu G; Denecke C; Jurisch A; Kim I; Li H; Yuan X; Ge X; ElKhal A; Tullius SG
Transplantation; 2016 Jan; 100(1):69-79. PubMed ID: 26356176
[TBL] [Abstract][Full Text] [Related]
13. Ablation of Transcription Factor IRF4 Promotes Transplant Acceptance by Driving Allogenic CD4
Wu J; Zhang H; Shi X; Xiao X; Fan Y; Minze LJ; Wang J; Ghobrial RM; Xia J; Sciammas R; Li XC; Chen W
Immunity; 2017 Dec; 47(6):1114-1128.e6. PubMed ID: 29221730
[TBL] [Abstract][Full Text] [Related]
14. CD27low natural killer cells prolong allograft survival in mice by controlling alloreactive CD8+ T cells in a T-bet-dependent manner.
Lantow M; Eggenhofer E; Sabet-Baktach M; Renner P; Rovira J; Koehl GE; Schlitt HJ; Geissler EK; Kroemer A
Transplantation; 2015 Feb; 99(2):391-9. PubMed ID: 25606781
[TBL] [Abstract][Full Text] [Related]
15. Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure.
Metzler B; Gfeller P; Wieczorek G; Li J; Nuesslein-Hildesheim B; Katopodis A; Mueller M; Brinkmann V
Int Immunol; 2008 May; 20(5):633-44. PubMed ID: 18343890
[TBL] [Abstract][Full Text] [Related]
16. IL-1 Receptor Signaling on Graft Parenchymal Cells Regulates Memory and De Novo Donor-Reactive CD8 T Cell Responses to Cardiac Allografts.
Iida S; Tsuda H; Tanaka T; Kish DD; Abe T; Su CA; Abe R; Tanabe K; Valujskikh A; Baldwin WM; Fairchild RL
J Immunol; 2016 Mar; 196(6):2827-37. PubMed ID: 26856697
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
Buonocore S; Flamand V; Goldman M; Braun MY
Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
Newell KA; He G; Guo Z; Kim O; Szot GL; Rulifson I; Zhou P; Hart J; Thistlethwaite JR; Bluestone JA
J Immunol; 1999 Sep; 163(5):2358-62. PubMed ID: 10452966
[TBL] [Abstract][Full Text] [Related]
19. CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection.
Harper SJ; Ali JM; Wlodek E; Negus MC; Harper IG; Chhabra M; Qureshi MS; Mallik M; Bolton E; Bradley JA; Pettigrew GJ
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12788-93. PubMed ID: 26420874
[TBL] [Abstract][Full Text] [Related]
20. CD8(+) T cells resistant to costimulatory blockade are controlled by an antagonist interleukin-15/Fc protein.
Ferrari-Lacraz S; Zheng XX; Fueyo AS; Maslinski W; Moll T; Strom TB
Transplantation; 2006 Dec; 82(11):1510-7. PubMed ID: 17164724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
